{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12769653",
  "DateCompleted": {
    "Year": "2003",
    "Month": "07",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "11",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1568-0061",
      "JournalIssue": {
        "Volume": "2",
        "Issue": "1",
        "PubDate": {
          "Year": "2002",
          "Month": "Jun"
        }
      },
      "Title": "Current drug targets. Cardiovascular & haematological disorders",
      "ISOAbbreviation": "Curr Drug Targets Cardiovasc Haematol Disord"
    },
    "ArticleTitle": "Ca2+-dependent signaling pathways in the heart: potential drug targets for cardiac disease.",
    "Pagination": {
      "StartPage": "1",
      "EndPage": "11",
      "MedlinePgn": "1-11"
    },
    "Abstract": {
      "AbstractText": [
        "Ca2+ is an important secondary messenger and any alteration to intracellular Ca2+ signaling pathways or components of these pathways can have a profound physiological effect on any cell, particularly cardiomyocytes. Early approaches to investigate heart disease focused on many muscle proteins, however recent findings indicate that molecules considered as \"non-muscle\" proteins may be equally important players in etiology of many cardiac pathologies. Many of these \"non-muscle\" proteins play a role in Ca2+ cycling or Ca2+ -dependent signaling pathways in the heart. In this review we focus on Ca2+ -dependent pathways in normal, growing, and diseased hearts. Understanding of these unique signaling pathways may hold answers to many cardiac pathologies in children and adults."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Membrane Proteins Research Group, Canadian Institutes of Health, Edmonton, Alberta, Canada T6G 2H7."
          }
        ],
        "LastName": "Lynch",
        "ForeName": "Jeffrey",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Michalak",
        "ForeName": "Marek",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Curr Drug Targets Cardiovasc Haematol Disord",
    "NlmUniqueID": "101123341",
    "ISSNLinking": "1568-0061"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Calcium Signaling"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Drug Delivery Systems"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Heart"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    }
  ],
  "NumberOfReferences": "139"
}